SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001181431-13-062489
Filing Date
2013-12-12
Accepted
2013-12-12 14:58:28
Documents
1
Period of Report
2013-12-11

Document Format Files

Seq Description Document Type Size
1 FORM 3 rrd395731.html 3  
1 FORM 3 rrd395731.xml 3 11099
  Complete submission text file 0001181431-13-062489.txt   13316
Mailing Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320
Business Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320 (805)447-1000
AMGEN INC (Reporting) CIK: 0000318154 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-36208 | Film No.: 131273229
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 343 PHOENIXVILLE PIKE MALVERN PA 19355
Business Address 343 PHOENIXVILLE PIKE MALVERN PA 19355 610-889-9900
TETRALOGIC PHARMACEUTICALS CORP (Issuer) CIK: 0001361248 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320-1799
Business Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320-1799 805-447-1000
Amgen Ventures LLC (Reporting) CIK: 0001576997 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-36208 | Film No.: 131273228